Labshake search
Citations for Bio X Cell :
1 - 50 of 681 citations for 9 10 Dihydro 4H benzo 4 5 cyclohepta 1 2 b thiophen 4 one since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Microbiology 2021Quote: ... 10 μg·ml-1 anti-IL-4 and 10 μg·ml-1 anti-IL-2 (Bio X Cell, Cat# BE0043-1, RRID:AB_1107705). For Treg cell differentiation ...
-
bioRxiv - Immunology 2019Quote: ... αIL-4 (5 μg mL−1, clone 11B11; Bio X Cell), rhTGF-β1 (2 ng mL−1 ...
-
bioRxiv - Cancer Biology 2021Quote: Mice were treated with either IgG (5 mg/kg as an anti-4-1BB control, 10 mg/kg as an anti-PD-1 control, BioXcell), anti-4-1BB agonist (5 mg/kg ...
-
bioRxiv - Immunology 2020Quote: ... and anti-IL-4 (10 µg/ml, BioXCell). Th1 cells were then cultured ...
-
bioRxiv - Immunology 2023Quote: ... into Th1 cells – 10 ng mL-1 rmIL-12 (R&D Biosystems) plus anti-IL-4 (10 μg mL-1, BioXcell), or Th17 – rhTGFβ (3 ng mL-1 ...
-
bioRxiv - Cancer Biology 2021Quote: ... anti-4-1BB agonist (5 mg/kg, clone: 3H3, BioXcell), or anti-PD-1 (10 mg/kg ...
-
bioRxiv - Immunology 2021Quote: ... TREG conditions: anti–IL-4 (10 μg/mL, BioXCell, #BE0045), anti-IFN-γ (10 μg/mL ...
-
bioRxiv - Immunology 2022Quote: ... and 10 μg/mL a-IL-4 (clone 11B11, BioXCell). For Th17 conditions ...
-
bioRxiv - Immunology 2021Quote: ... plus 2 µg/mL anti-IL-4 antibody (BioXcell, Clone: 11B11); Th17 ...
-
bioRxiv - Immunology 2023Quote: ... or 4-1BB (5 µg/ml, clone 3H3, BE0239) all from BioXCell. Unless otherwise stated ...
-
bioRxiv - Cancer Biology 2024Quote: ... and/or 5 mg/kg anti-CTLA-4 (clone 9H10, cat. BE0131, BioXcell). Antibodies were dissolved in PBS and administered via intraperitoneal injection (4 μl/g ...
-
bioRxiv - Genomics 2022Quote: ... 10 μg/mL of anti-IL-4 (Clone: 11B11, BioXCell, Cat# BE0045), 2 ng/mL of recombinant TGFβ (BioLegend ...
-
bioRxiv - Immunology 2021Quote: ... 1% GlutaMAX™ and 1% N-2-hydroxyethylpiperazine-N-2-ethane sulfonic acid [Gibco® HEPES]) and used as follow: TH1 conditions with anti–IL-4 (10 μg/mL, BioXCell, #BE0045) and IL-12 (10 ng/mL ...
-
bioRxiv - Immunology 2023Quote: ... They were differentiated (9) for 2 days with plate bound anti-CD3 and anti-CD28 (2 μg mL-1 each; BioXcell) into Th1 cells – 10 ng mL-1 rmIL-12 (R&D Biosystems ...
-
bioRxiv - Cancer Biology 2024Quote: Antibody administration of anti-VLA-4 (clone PS/2, Bio X Cell #BE0071), anti-4-1BB (clone LOB12.3 ...
-
bioRxiv - Immunology 2024Quote: ... and 10 μg/ml of anti-IL-4 mAb (#BE0045, BioXCell, Lebanon, NH); (c ...
-
bioRxiv - Immunology 2021Quote: ... 2 µg/mL anti-IL-4 and anti-IFNγ antibody (BioXcell, Clone: XMG 1.2). 10 µM SB525334 was used to replace TGF-β to inhibit TGF-β signaling if required ...
-
bioRxiv - Bioengineering 2023Quote: ... Mice in groups receiving αPD-1 and αCTLA-4 (100 µg, every 3 days for 5 injections, BioXcell, West Lebanon NH) were treated intraperitoneally ...
-
bioRxiv - Bioengineering 2023Quote: ... Mice in groups receiving αPD-1 and αCTLA-4 (100 µg, every 3 days for 4 injections, BioXcell, West Lebanon NH) were treated intraperitoneally ...
-
bioRxiv - Immunology 2022Quote: ... 5 ug/ml Brefeldin A was supplemented 4 hrs before subsequent Fc blocking (2.4G2, BioXCell), surface antibody staining ...
-
bioRxiv - Microbiology 2021Quote: ... naïve CD4+ T cells were cultured with 10 ng·ml-1 IL-12 (R&D, Cat# 402-ML-020/CF) and 10 μg·ml-1 anti-IL-4 (Bio X Cell, Cat# BE0045, RRID:AB_1107707). For Th17 cell differentiation ...
-
bioRxiv - Immunology 2021Quote: ... and anti-IL-4 (BioXCell); for Th2 ...
-
bioRxiv - Immunology 2023Quote: ... and 10 μg/ml of anti-IL-4 mAb (Bio X Cell Cat# BE0045 RRID:AB_1107707); (c ...
-
bioRxiv - Immunology 2019Quote: ... For Th2 induction 1×105 naïve T cells were cultured for 4 days with plate-bound αCD3ε (10 μg mL−1, clone 145-2C11; Bio X Cell) and αCD28 (10 μg mL−1 ...
-
bioRxiv - Immunology 2019Quote: ... 2 to 3×105 naïve T cells were cultured for 4 days with plate-bound αCD3ε (10 μg mL−1, clone 145-2C11; Bio X Cell), αCD28 (1 μg/mL ...
-
bioRxiv - Immunology 2020Quote: ... LFA blocking antibody (M17/4; BioXCell) was administered i.p ...
-
bioRxiv - Cancer Biology 2020Quote: ... and anti-CTLA-4 (BioXCell, BE0164) or isotype control (MSD IgG1 control for muDX400 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and anti-CTLA-4 (BioXCell # BE0164) were diluted in PBS and dosed at 10 mg/kg every 3 days ...
-
bioRxiv - Cancer Biology 2021Quote: ... 250 μg PD-1 and CTLA-4 blocking (clone 9H10, BioXCell, Lebanon, NH) antibodies were injected intraperitoneally thrice per week for four weeks or a combination of PD-1 CTLA-4 antibodies with iBET762 were used.
-
bioRxiv - Immunology 2022Quote: ... or combination of PD-1 and CTLA-4 using anti-PD-1 (clone: RMP1-14, BioXcell), anti-CTLA-4 (clone ...
-
bioRxiv - Cancer Biology 2023Quote: ... or isotype control antibody (200μg twice weekly for 2 weeks, a total of 4 times; clone LTF2, BioXcell).
-
bioRxiv - Immunology 2024Quote: ... and IL-4-reactive monoclonal antibodies for in vivo studies (IL-4 MAb) were purchased from BioXCell (BE0045). All TLR agonists were purchased from Invivogen ...
-
bioRxiv - Immunology 2020Quote: ... each of anti-LFA-1 and anti-VLA-4 blocking antibodies (Bio X Cell) or control IgG ...
-
bioRxiv - Immunology 2019Quote: ... with 5 μg purified anti-mouse IL-2 antibody (JES6-1, BioXcell) for 30 min at 37°C (molar ratio for IL2:anti-IL-2 is 2:1) ...
-
bioRxiv - Immunology 2019Quote: ... anti-IL-4 (BioXcell, 11B11, 10ug/mL), IL-12 (Peprotech ...
-
bioRxiv - Cancer Biology 2021Quote: ... and anti-4-1BB (clone LOB12.3, BioXCell) treatment ...
-
bioRxiv - Immunology 2022Quote: ... and 3μg/mL anti–IL-4 (BioXcell) were used ...
-
bioRxiv - Immunology 2023Quote: Studies of anti-CTLA-4 (BE0032, BioXcell) therapy in mice bearing CT26 and B16 tumors ...
-
bioRxiv - Immunology 2022Quote: ... Inhibition of CTLA-4 signaling was performed by intraperitoneal injection of 500μg/dose of αCTLA-4 (clone: UC10-4F10-11, BioXcell) supplemented with 1mg/dose of IgG2b isotype (clone ...
-
bioRxiv - Cancer Biology 2023Quote: ... injection of either a-PD-L1 antibody (200μg twice weekly for 2 weeks, a total of 4 times; clone 10F.9G2, BioXcell) or isotype control antibody (200μg twice weekly for 2 weeks ...
-
bioRxiv - Cancer Biology 2024Quote: ... Anti-murine PD-1 and anti-murine CTLA-4 were purchased from Bio X Cell (BE0146-clone RMP1-14 ...
-
bioRxiv - Immunology 2022Quote: ... anti-CTLA-4 (clone: UC10-4F10-11, BioXcell) or isotype control antibodies (clone ...
-
bioRxiv - Immunology 2023Quote: ... and anti-IL-4 antibody (clone 11B11, BioXCell) at a concentration of 10 µg/ml ...
-
bioRxiv - Immunology 2023Quote: ... and anti-IL-4 Ab (clone 11B11, BioXCell) at a concentration of 10 µg/ml ...
-
bioRxiv - Immunology 2021Quote: ... CTLs were pre-incubated with LFA-1 blocking antibody (20 μg/mL, Clone M17/4, BioXCell) or an IgG2aκ isotype control antibody (20 μg/mL ...
-
bioRxiv - Immunology 2020Quote: ... The following soluble TNFRSF agonists were used to co-stimulate Tregs: anti-4-1BB mAb (10 μg/ml, 3H3, BioXcell), OX40L (100 ng/ ml ...
-
bioRxiv - Immunology 2023Quote: ... Th1 cells were generated by addition of IL-12 at a concentration of 10 ng/ml and anti-IL-4 antibody (clone 11B11, BioXCell) at a concentration of 10 µg/ml into the culture ...
-
bioRxiv - Immunology 2023Quote: ... Th1 cells were generated by addition of IL-12 at a concentration of 10 ng/ml and anti-IL-4 antibody (clone 11B11, BioXCell) at a concentration of 10 µg/ml into the culture ...
-
bioRxiv - Immunology 2020Quote: ... IL-2 (10 unit/mL) and anti-human CD40 (1 μg/mL; BioXcell). Human B cell proliferation was measured by 3[H]-thymidine incorporation (1 μCi/mL ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 200 µg of anti-CTLA-4 (BioXCell BE0164), or 400 µg of anti-IgG2b isotype control (BioXCell BE0090) ...